Literature DB >> 1687852

Pharmacodynamic interactions between infused adenosine and oral theophylline.

N A Minton1, J A Henry.   

Abstract

1. Five healthy human subjects were given, in single-blind fashion, either (a) 625 mg theophylline orally, followed 4 h later, by a 40 min infusion of adenosine (40 micrograms kg-1 min-1 for 5 min, 60 micrograms kg-1 min-1 for 5 min and 80 micrograms kg-1 min-1 for 30 min), or (b) 625 mg theophylline orally followed by 0.9% sodium chloride infusion, or (c) placebo theophylline tablets followed by adenosine infusion. 2. All five subjects experienced adverse effects during adenosine infusion, mainly at the higher infusion rates; two subjects also experienced chest pain but not during combined treatment with theophylline and adenosine. 3. Diastolic blood pressure (DBP) rose by 16.5 mmHg (P less than 0.001) following treatment with theophylline only, fell by 24.5 mmHg (P less than 0.001) during the adenosine infusion after placebo theophylline and remained unchanged during the adenosine infusion following theophylline. Pulse rate rose by 12 min-1 (P less than 0.01) during adenosine infusion following placebo, but not after theophylline alone or theophylline and adenosine combined. 4. The respiratory rate fell by 6 min-1 (P less than 0.01) during treatment with adenosine only, being lower than for the two treatments containing theophylline (P less than 0.05). 5. Plasma potassium and magnesium fell by 0.25 mmol l-1 (P less than 0.001) and 0.037 mmol l-1 (P less than 0.05), respectively, during treatment with theophylline only, but these effects were not altered by infusion of adenosine. 6. This study has demonstrated interactions between theophylline and adenosine on diastolic blood pressure and respiratory rate, but no interaction on metabolic parameters.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1687852     DOI: 10.1177/096032719101000608

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  3 in total

Review 1.  Oesophageal motor functions and its disorders.

Authors:  R K Mittal; V Bhalla
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

2.  An open-label trial of theophylline for functional chest pain.

Authors:  Satish S C Rao; Ranjit S Mudipalli; Victor Mujica; Craig L Utech; Xing Zhao; Jeffrey L Conklin
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

3.  Investigation of esophageal sensation and biomechanical properties in functional chest pain.

Authors:  I Nasr; A Attaluri; S Hashmi; H Gregersen; S S C Rao
Journal:  Neurogastroenterol Motil       Date:  2010-01-12       Impact factor: 3.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.